Download Free Emerging Drugs In Sport Book in PDF and EPUB Free Download. You can read online Emerging Drugs In Sport and write the review.

Athletes are always aiming to be faster, better, stronger. New techniques to enhance their sporting performance have increasingly been linked to use of novel psychoactive substances (NPS) and other hard-to-detect substances like performance-enhancing drugs. This book offers a timely analysis of the new challenges posed by this phenomenon in the anti-doping community. The authors present the first comprehensive perspective on the rapidly shifting doping scenario and reflect on use, regulation, policy, and market structure of NPS used in sports. They highlight the challenges with the list of prohibited substances and methods in and out of competition. They also evaluate how methods to detect new drugs present an ongoing battle for doping control as they have to be adapted constantly. Topics covered within the chapters include: Contamination of Sports Supplements with Novel Psychoactive Substances Untested Supplement Use Among Athletes: An Overlooked Phenomenon? International Drug Control: Protecting the Health of the Athlete Analysis of New Chemical Entities in a Sport Context Emerging Drugs in Sport establishes a clear benchmark on the policy discussion, drawing from available evidence and sources, including athletes' personal experiences, to generate a fact-based resource that informs a research as well as wider audience. The book is essential reading for those working in anti-doping, substance misuse, sports, ethics, and human enhancement. It also is useful for policy-makers, legislative personnel, and other professionals with an interest in protecting clean sport. "Doping is one of the greatest threats to the integrity of sport. We must never be tempted to turn our back on the problem and hope it will disappear. The benefits and values of clean sport have never been more important to the world. That is why this book with its wide-ranging approach is so valuable." Thomas Bach, President, International Olympic Committee "Physical activity is vital to a healthy living, which is why doping is not just an assault on fair competition, but also on health. I strongly commend this book for compiling advanced knowledge on performance-enhancing drugs and promoting health through sport." Tedros Adhanom Ghebreyesus, Director-General, World Health Organization.
Doping, Performance-Enhancing Drugs, and Hormones in Sport: Mechanisms of Action and Methods of Detection examines the biochemistry and bioanalytical aspects of performance-enhancing drugs (PEDs) and other questionable procedures used by athletes to enhance performance. The book informs the specialist of emerging knowledge and techniques and allows the non-specialist to grasp the underlying science and current practice of the discipline. With clear and compelling language appropriate for a broad spectrum of readers, this book provides background on prevalence, types of agents, their actual or supposed benefits, and their negative effects on health. The technical aspects of detection are discussed, followed by a discussion of why detection is a problematic and still-evolving science. To facilitate comprehension, each chapter is organized in a uniform way with six sections: (1) standard medical uses, (2) why the drugs are used by athletes, (3) biological mechanism of action, (4) what research says about efficacy in improving performance, (5) major health side effects from use and abuse in sport, and 6) concluding key points. - Presents the scientific concepts of how performance enhancers work, how they are used, and how they are detected and masked from detection - Features language that is neither simplistic to scientists nor too sophisticated for a large, diverse global audience - Provides a short "close-up in each chapter to illustrate key topics that engage, entertain, and create a novel synthesis of thought
Athletes are always aiming to be faster, better, stronger. New techniques to enhance their sporting performance have increasingly been linked to use of novel psychoactive substances (NPS) and other hard-to-detect substances like performance-enhancing drugs. This book offers a timely analysis of the new challenges posed by this phenomenon in the anti-doping community. The authors present the first comprehensive perspective on the rapidly shifting doping scenario and reflect on use, regulation, policy, and market structure of NPS used in sports. They highlight the challenges with the list of prohibited substances and methods in and out of competition. They also evaluate how methods to detect new drugs present an ongoing battle for doping control as they have to be adapted constantly. Topics covered within the chapters include: Contamination of Sports Supplements with Novel Psychoactive Substances Untested Supplement Use Among Athletes: An Overlooked Phenomenon? International Drug Control: Protecting the Health of the Athlete Analysis of New Chemical Entities in a Sport Context Emerging Drugs in Sport establishes a clear benchmark on the policy discussion, drawing from available evidence and sources, including athletes' personal experiences, to generate a fact-based resource that informs a research as well as wider audience. The book is essential reading for those working in anti-doping, substance misuse, sports, ethics, and human enhancement. It also is useful for policy-makers, legislative personnel, and other professionals with an interest in protecting clean sport. “Doping is one of the greatest threats to the integrity of sport. We must never be tempted to turn our back on the problem and hope it will disappear. The benefits and values of clean sport have never been more important to the world. That is why this book with its wide-ranging approach is so valuable.” Thomas Bach, President, International Olympic Committee “Physical activity is vital to a healthy living, which is why doping is not just an assault on fair competition, but also on health. I strongly commend this book for compiling advanced knowledge on performance-enhancing drugs and promoting health through sport.” Tedros Adhanom Ghebreyesus, Director-General, World Health Organization
In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches also in less explored settings such as prisons and sport environments. Overall, this highly informative and well-structured repository of different experiences with NPS policy, law and regulation offers an essential primary source of evidence for anyone interested in the area of drug and NPS policy, health economics and p ublic health.
Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein
Forty years ago, President Richard Nixon declared a “war on drugs.” Since that time, the country has incarcerated thousands of citizens and spent billions of dollars, and yet the drug problem rolls on. Today, the illegal drug market funds international terrorism, the horrific drug war on the Mexican border, and the senseless violence plaguing our communities, large and small. It is past time for a new direction. This book provides a drug policy framework that will choke off the revenue supporting the illegal drug market. Howard Rahtz outlines a series of drug policy steps buttressed by a historical review of drug policy measures, a review of international efforts against trafficking, and a clear understanding of the dynamics of addiction and its role in facilitating the illegal drug market.
Social Issues in Sport, Fourth Edition, explores common questions and issues about sport and its relation to society through various sociological and cultural lenses. The text is grounded in practical application and provides social theories through which students may examine real-world issues
​​This book examines sports doping from production and distribution, detection and punishment. Detailing the daily operations of the trade and its gray area as a semi-legal market, the authors cover important issues ranging from athletes most at risk to the role of organized crime in sports doping, and whether sports governing bodies are enabling the trade. Challenges for law enforcement and legislation, and efforts to control PED use in the worldwide sports community and among aspiring athletes, are also discussed in depth. The book's extensive research:• Estimates the demand for performance-enhancing products. • Traces the route from legal substances to illegal uses. • Identifies classes of suppliers and their methods of operation. • Tracks typical distribution systems from suppliers to users. • Examines the economics of the market: prices, profits, revenue. • Assesses the state of anti-doping law enforcement efforts.Starting with an unprecedented case study in Italy, the intense scrutiny from one pivotal country yields a potential template for research and policy on a world scale. Doping and Sport makes solid contributions to the work of researchers in criminology and criminal justice, particularly with an interest in corruption, drug trafficking, and criminal networks; researchers in sports science and public health; and policymakers.
This book is about gym culture, the pursuit of fit, muscular bodies and the use of drugs as a means to get there. Building on the international research literature and in-depth interviews with men who have experience of image and performance enhancing drugs (IPEDs), the book explores the fascination with muscles, motivations for using drugs to enhance them, assessments of risks, and experience of side effects. The book examines what the altered body does to the men’s identity, self-image and relationships with peers and partners. Taking an evolutionary psychological approach, it also investigates the biological and psychological foundations of the fascination with the muscular body and discusses the notion of precarious manhood. Building on these analyses the book considers the political and regulatory initiatives in place to prevent the use of IPEDs and assesses those strategies’ potential to reach their aims. This is essential reading for anybody with an interest in the issue of drugs in sport, the ethics of sport, sociology of sport, sociology of the body, masculinity or public health.
Discusses the use of performance-enhancing drugs among high school and Olympic athletes and efforts to ban drug and steroid use in sports from a variety of viewpoints.